comparemela.com

Latest Breaking News On - Professor hasnain - Page 2 : comparemela.com

Interleukin-22 study provides better understanding of immune responses in inflammatory bowel and lung disease

Interleukin-22 study provides better understanding of immune responses in inflammatory bowel and lung disease
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Sumaira-hasnain
Experimental-medicine
Associate-professor-sumaira-hasnain
Major-histocompatibility-complex
Mucosal-epithelial-cells
Professor-hasnain

Breakthrough Understanding of Immune Responses in IBD and Lung Disease

Breakthrough Understanding of Immune Responses in IBD and Lung Disease
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Sumaira-hasnain
Mater-researchers
Associate-professor-sumaira-hasnain
Experimental-medicine
Major-histocompatibility-complex
Mucosal-epithelial
Professor-hasnain
Associate-professor-hasnain

University of Queensland startup gets $1.3 million international backing for liver disease treatment

University of Queensland startup gets $1.3 million international backing for liver disease treatment
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.

Australia
Melbourne
Victoria
John-prins
Mike-mcguckin
Mike-molinari
Sumaira-hasnain
Jetra-therapeutics-pty-ltd
Ip-group
Mater-research
University-of-melbourne
Immunopathology-group-leader

UQ startup gets $1.3 million international backing for liver disease treatment

A University of Queensland startup company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of

Australia
Melbourne
Victoria
John-prins
Mike-mcguckin
Mike-molinari
Sumaira-hasnain
Jetra-therapeutics-pty-ltd
Ip-group
Mater-research
University-of-melbourne
Immunopathology-group-leader

UQ start-up secures $1.3 million seed investment to develop new treatment for liver disease

A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.

Australia
Melbourne
Victoria
John-prins
Mike-mcguckin
Mike-molinari
Sumaira-hasnain
Emily-henderson
Jetra-therapeutics-pty-ltd
Ip-group
Mater-research
University-of-melbourne

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.